[1]
V. C. Sangar, B. B. Ghongane, R. Gupte, R. Kesarkar, K. Kalyan, and A. Chowdhary, “COMPARISON OF POST-LICENSURE SAFETY SURVEILLANCE OF BIVALENT AND QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINES IN HEALTHY MUMBAI WOMEN”, Int J Pharm Pharm Sci, vol. 7, no. 3, pp. 437–442, Mar. 2015.